Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial

Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients

(2013) David J. Becker   ANNALS OF INTERNAL MEDICINE

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

(2013) Heart Protection Study Collaborative Group   LANCET

Effect of Coenzyme Q10 Supplementation on Statin-Induced Myalgias

(2012) David A. Bookstaver et al.   AMERICAN JOURNAL OF CARDIOLOGY

Strategies to preserve the use of statins in patients with previous muscular adverse effects

(2012) K. M. Reinhart et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Cardiovascular Primary Prevention

(2012) Andrae Vandross   ARCHIVES OF INTERNAL MEDICINE

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Statins for people at low risk of cardiovascular disease – Authors' reply

(2012) Borislava Mihaylova et al.   LANCET

LDL Cholesterol: The Lower the Better

(2012) Seth S. Martin et al.   MEDICAL CLINICS OF NORTH AMERICA

Clinical response to statins: Mechanism(s) of variable activity and adverse effects

(2011) Cesare R. Sirtori et al.   ANNALS OF MEDICINE

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference

(2011) G.B. John Mancini et al.   CANADIAN JOURNAL OF CARDIOLOGY

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

(2011) M. Tonelli et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins

(2010) Carmelo V. Venero et al.   AMERICAN JOURNAL OF CARDIOLOGY

Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials

(2010) Y. Lebenthal et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products

(2010) Ram Y. Gordon et al.   ARCHIVES OF INTERNAL MEDICINE

The Role of Red Yeast Rice for the Physician

(2010) Ram Y. Gordon et al.   Current Atherosclerosis Reports

Evidence-Based Management of Statin Myopathy

(2010) Charles R. Harper et al.   Current Atherosclerosis Reports

Approach to the Patient Who Is Intolerant of Statin Therapy

(2010) Robert H. Eckel   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)

(2009) Jian-Jun Li et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Functional foods for dyslipidaemia and cardiovascular risk prevention

(2009) Cesare R. Sirtori et al.   NUTRITION RESEARCH REVIEWS

Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction

(2008) Zongliang Lu et al.   AMERICAN JOURNAL OF CARDIOLOGY